Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial
Abstract To examine long-term effects of early intervention services (EIS) for first-episode psychosis, we compared Heinrichs-Carpenter Quality of Life (QLS) and Positive and Negative Syndrome Scale (PANSS) scores and inpatient hospitalization days over 5 years with data from the site-randomized RAI...
Gespeichert in:
Veröffentlicht in: | Schizophrenia bulletin 2022-09, Vol.48 (5), p.1021-1031 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1031 |
---|---|
container_issue | 5 |
container_start_page | 1021 |
container_title | Schizophrenia bulletin |
container_volume | 48 |
creator | Robinson, Delbert G Schooler, Nina R Marcy, Patricia Gibbons, Robert D Hendricks Brown, C John, Majnu Mueser, Kim T Penn, David L Rosenheck, Robert A Addington, Jean Brunette, Mary F Correll, Christoph U Estroff, Sue E Mayer-Kalos, Piper S Gottlieb, Jennifer D Glynn, Shirley M Lynde, David W Gingerich, Susan Pipes, Ronny Miller, Alexander L Severe, Joanne B Kane, John M |
description | Abstract
To examine long-term effects of early intervention services (EIS) for first-episode psychosis, we compared Heinrichs-Carpenter Quality of Life (QLS) and Positive and Negative Syndrome Scale (PANSS) scores and inpatient hospitalization days over 5 years with data from the site-randomized RAISE-ETP trial that compared the EIS NAVIGATE (17 sites; 223 participants) and community care (CC) (17 sites; 181 participants). Inclusion criteria were: age 15–40 years; DSM-IV diagnoses of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, or psychotic disorder not otherwise specified; first psychotic episode; antipsychotic medication taken for ≤6 months. NAVIGATE-randomized participants could receive NAVIGATE from their study entry date until NAVIGATE ended when the last-enrolled NAVIGATE participant completed 2 years of treatment. Assessments occurred every 6 months. 61% of participants had assessments conducted ≥2 years; 31% at 5 years. Median follow-up length was CC 30 months and NAVIGATE 38 months. Primary analyses assumed data were not-missing-at-random (NMAR); sensitivity analyses assumed data were missing-at-random (MAR). MAR analyses found no significant treatment-by-time interactions for QLS or PANSS. NMAR analyses revealed that NAVIGATE was associated with a 13.14 (95%CI:6.92,19.37) unit QLS and 7.73 (95%CI:2.98,12.47) unit PANSS better improvement and 2.53 (95%CI:0.59,4.47) fewer inpatient days than CC (all comparisons significant). QLS and PANSS effect sizes were 0.856 and 0.70. NAVIGATE opportunity length (mean 33.8 (SD = 5.1) months) was not associated (P = .72) with QLS outcome; duration of untreated psychosis did not moderate (P = .32) differential QLS outcome. While conclusions are limited by the low rate of five-year follow-up, the data support long-term benefit of NAVIGATE compared to community care. |
doi_str_mv | 10.1093/schbul/sbac053 |
format | Article |
fullrecord | <record><control><sourceid>oup_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9434430</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/schbul/sbac053</oup_id><sourcerecordid>10.1093/schbul/sbac053</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-46201785a8dddc6b1a486afb198c572004c6ee02a7c21f330db26ba8b18a96c43</originalsourceid><addsrcrecordid>eNqFkcFPwjAUxhujEUSvHk2vHgbt1nWdBxOCQ0lIIIAHT0vXdVCzraTdSPCv8E-2BiR68vS-5H3f7-XlA-AWoz5GcTCwYpO15cBmXKAwOANdHJHQwxHC56CLQka9iGLSAVfWviOESUz9S9AJQspiErEu-Jy1jdCVtPCpNapeQ17ncFg00sCEm3IPJ7XTO1k3Stdw6aQSzlxoA8fK2MZLtsrqXMK53YuNtso-wIW0bdlYONs5SgjfJDcWjo2uYLORcDGcLBMvWc3hUjXSW7iDulIfMocro3h5DS4KXlp5c5w98DpOVqMXbzp7noyGU08QnzQeoT7CEQs5y_Nc0AxzwigvMhwzEUY-QkRQKZHPI-HjIghQnvk04yzDjMdUkKAHHg_cbZtVMhfuQ8PLdGtUxc0-1Vylfze12qRrvUtjEhASIAfoHwDCaGuNLE5ZjNLvbtJDN-mxGxe4-33xZP8pwxnuDwbdbv-DfQGPxJ3w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Robinson, Delbert G ; Schooler, Nina R ; Marcy, Patricia ; Gibbons, Robert D ; Hendricks Brown, C ; John, Majnu ; Mueser, Kim T ; Penn, David L ; Rosenheck, Robert A ; Addington, Jean ; Brunette, Mary F ; Correll, Christoph U ; Estroff, Sue E ; Mayer-Kalos, Piper S ; Gottlieb, Jennifer D ; Glynn, Shirley M ; Lynde, David W ; Gingerich, Susan ; Pipes, Ronny ; Miller, Alexander L ; Severe, Joanne B ; Kane, John M</creator><creatorcontrib>Robinson, Delbert G ; Schooler, Nina R ; Marcy, Patricia ; Gibbons, Robert D ; Hendricks Brown, C ; John, Majnu ; Mueser, Kim T ; Penn, David L ; Rosenheck, Robert A ; Addington, Jean ; Brunette, Mary F ; Correll, Christoph U ; Estroff, Sue E ; Mayer-Kalos, Piper S ; Gottlieb, Jennifer D ; Glynn, Shirley M ; Lynde, David W ; Gingerich, Susan ; Pipes, Ronny ; Miller, Alexander L ; Severe, Joanne B ; Kane, John M</creatorcontrib><description>Abstract
To examine long-term effects of early intervention services (EIS) for first-episode psychosis, we compared Heinrichs-Carpenter Quality of Life (QLS) and Positive and Negative Syndrome Scale (PANSS) scores and inpatient hospitalization days over 5 years with data from the site-randomized RAISE-ETP trial that compared the EIS NAVIGATE (17 sites; 223 participants) and community care (CC) (17 sites; 181 participants). Inclusion criteria were: age 15–40 years; DSM-IV diagnoses of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, or psychotic disorder not otherwise specified; first psychotic episode; antipsychotic medication taken for ≤6 months. NAVIGATE-randomized participants could receive NAVIGATE from their study entry date until NAVIGATE ended when the last-enrolled NAVIGATE participant completed 2 years of treatment. Assessments occurred every 6 months. 61% of participants had assessments conducted ≥2 years; 31% at 5 years. Median follow-up length was CC 30 months and NAVIGATE 38 months. Primary analyses assumed data were not-missing-at-random (NMAR); sensitivity analyses assumed data were missing-at-random (MAR). MAR analyses found no significant treatment-by-time interactions for QLS or PANSS. NMAR analyses revealed that NAVIGATE was associated with a 13.14 (95%CI:6.92,19.37) unit QLS and 7.73 (95%CI:2.98,12.47) unit PANSS better improvement and 2.53 (95%CI:0.59,4.47) fewer inpatient days than CC (all comparisons significant). QLS and PANSS effect sizes were 0.856 and 0.70. NAVIGATE opportunity length (mean 33.8 (SD = 5.1) months) was not associated (P = .72) with QLS outcome; duration of untreated psychosis did not moderate (P = .32) differential QLS outcome. While conclusions are limited by the low rate of five-year follow-up, the data support long-term benefit of NAVIGATE compared to community care.</description><identifier>ISSN: 0586-7614</identifier><identifier>EISSN: 1745-1701</identifier><identifier>DOI: 10.1093/schbul/sbac053</identifier><identifier>PMID: 35689478</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Adolescent ; Adult ; Antipsychotic Agents - therapeutic use ; Diagnostic and Statistical Manual of Mental Disorders ; Humans ; Psychotic Disorders - diagnosis ; Quality of Life ; Regular ; Schizophrenia - drug therapy ; Young Adult</subject><ispartof>Schizophrenia bulletin, 2022-09, Vol.48 (5), p.1021-1031</ispartof><rights>The Author(s) 2022. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com 2022</rights><rights>The Author(s) 2022. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-46201785a8dddc6b1a486afb198c572004c6ee02a7c21f330db26ba8b18a96c43</citedby><cites>FETCH-LOGICAL-c424t-46201785a8dddc6b1a486afb198c572004c6ee02a7c21f330db26ba8b18a96c43</cites><orcidid>0000-0001-6606-4507</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434430/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434430/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,1578,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35689478$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Robinson, Delbert G</creatorcontrib><creatorcontrib>Schooler, Nina R</creatorcontrib><creatorcontrib>Marcy, Patricia</creatorcontrib><creatorcontrib>Gibbons, Robert D</creatorcontrib><creatorcontrib>Hendricks Brown, C</creatorcontrib><creatorcontrib>John, Majnu</creatorcontrib><creatorcontrib>Mueser, Kim T</creatorcontrib><creatorcontrib>Penn, David L</creatorcontrib><creatorcontrib>Rosenheck, Robert A</creatorcontrib><creatorcontrib>Addington, Jean</creatorcontrib><creatorcontrib>Brunette, Mary F</creatorcontrib><creatorcontrib>Correll, Christoph U</creatorcontrib><creatorcontrib>Estroff, Sue E</creatorcontrib><creatorcontrib>Mayer-Kalos, Piper S</creatorcontrib><creatorcontrib>Gottlieb, Jennifer D</creatorcontrib><creatorcontrib>Glynn, Shirley M</creatorcontrib><creatorcontrib>Lynde, David W</creatorcontrib><creatorcontrib>Gingerich, Susan</creatorcontrib><creatorcontrib>Pipes, Ronny</creatorcontrib><creatorcontrib>Miller, Alexander L</creatorcontrib><creatorcontrib>Severe, Joanne B</creatorcontrib><creatorcontrib>Kane, John M</creatorcontrib><title>Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial</title><title>Schizophrenia bulletin</title><addtitle>Schizophr Bull</addtitle><description>Abstract
To examine long-term effects of early intervention services (EIS) for first-episode psychosis, we compared Heinrichs-Carpenter Quality of Life (QLS) and Positive and Negative Syndrome Scale (PANSS) scores and inpatient hospitalization days over 5 years with data from the site-randomized RAISE-ETP trial that compared the EIS NAVIGATE (17 sites; 223 participants) and community care (CC) (17 sites; 181 participants). Inclusion criteria were: age 15–40 years; DSM-IV diagnoses of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, or psychotic disorder not otherwise specified; first psychotic episode; antipsychotic medication taken for ≤6 months. NAVIGATE-randomized participants could receive NAVIGATE from their study entry date until NAVIGATE ended when the last-enrolled NAVIGATE participant completed 2 years of treatment. Assessments occurred every 6 months. 61% of participants had assessments conducted ≥2 years; 31% at 5 years. Median follow-up length was CC 30 months and NAVIGATE 38 months. Primary analyses assumed data were not-missing-at-random (NMAR); sensitivity analyses assumed data were missing-at-random (MAR). MAR analyses found no significant treatment-by-time interactions for QLS or PANSS. NMAR analyses revealed that NAVIGATE was associated with a 13.14 (95%CI:6.92,19.37) unit QLS and 7.73 (95%CI:2.98,12.47) unit PANSS better improvement and 2.53 (95%CI:0.59,4.47) fewer inpatient days than CC (all comparisons significant). QLS and PANSS effect sizes were 0.856 and 0.70. NAVIGATE opportunity length (mean 33.8 (SD = 5.1) months) was not associated (P = .72) with QLS outcome; duration of untreated psychosis did not moderate (P = .32) differential QLS outcome. While conclusions are limited by the low rate of five-year follow-up, the data support long-term benefit of NAVIGATE compared to community care.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Diagnostic and Statistical Manual of Mental Disorders</subject><subject>Humans</subject><subject>Psychotic Disorders - diagnosis</subject><subject>Quality of Life</subject><subject>Regular</subject><subject>Schizophrenia - drug therapy</subject><subject>Young Adult</subject><issn>0586-7614</issn><issn>1745-1701</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFPwjAUxhujEUSvHk2vHgbt1nWdBxOCQ0lIIIAHT0vXdVCzraTdSPCv8E-2BiR68vS-5H3f7-XlA-AWoz5GcTCwYpO15cBmXKAwOANdHJHQwxHC56CLQka9iGLSAVfWviOESUz9S9AJQspiErEu-Jy1jdCVtPCpNapeQ17ncFg00sCEm3IPJ7XTO1k3Stdw6aQSzlxoA8fK2MZLtsrqXMK53YuNtso-wIW0bdlYONs5SgjfJDcWjo2uYLORcDGcLBMvWc3hUjXSW7iDulIfMocro3h5DS4KXlp5c5w98DpOVqMXbzp7noyGU08QnzQeoT7CEQs5y_Nc0AxzwigvMhwzEUY-QkRQKZHPI-HjIghQnvk04yzDjMdUkKAHHg_cbZtVMhfuQ8PLdGtUxc0-1Vylfze12qRrvUtjEhASIAfoHwDCaGuNLE5ZjNLvbtJDN-mxGxe4-33xZP8pwxnuDwbdbv-DfQGPxJ3w</recordid><startdate>20220901</startdate><enddate>20220901</enddate><creator>Robinson, Delbert G</creator><creator>Schooler, Nina R</creator><creator>Marcy, Patricia</creator><creator>Gibbons, Robert D</creator><creator>Hendricks Brown, C</creator><creator>John, Majnu</creator><creator>Mueser, Kim T</creator><creator>Penn, David L</creator><creator>Rosenheck, Robert A</creator><creator>Addington, Jean</creator><creator>Brunette, Mary F</creator><creator>Correll, Christoph U</creator><creator>Estroff, Sue E</creator><creator>Mayer-Kalos, Piper S</creator><creator>Gottlieb, Jennifer D</creator><creator>Glynn, Shirley M</creator><creator>Lynde, David W</creator><creator>Gingerich, Susan</creator><creator>Pipes, Ronny</creator><creator>Miller, Alexander L</creator><creator>Severe, Joanne B</creator><creator>Kane, John M</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6606-4507</orcidid></search><sort><creationdate>20220901</creationdate><title>Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial</title><author>Robinson, Delbert G ; Schooler, Nina R ; Marcy, Patricia ; Gibbons, Robert D ; Hendricks Brown, C ; John, Majnu ; Mueser, Kim T ; Penn, David L ; Rosenheck, Robert A ; Addington, Jean ; Brunette, Mary F ; Correll, Christoph U ; Estroff, Sue E ; Mayer-Kalos, Piper S ; Gottlieb, Jennifer D ; Glynn, Shirley M ; Lynde, David W ; Gingerich, Susan ; Pipes, Ronny ; Miller, Alexander L ; Severe, Joanne B ; Kane, John M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-46201785a8dddc6b1a486afb198c572004c6ee02a7c21f330db26ba8b18a96c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Diagnostic and Statistical Manual of Mental Disorders</topic><topic>Humans</topic><topic>Psychotic Disorders - diagnosis</topic><topic>Quality of Life</topic><topic>Regular</topic><topic>Schizophrenia - drug therapy</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Robinson, Delbert G</creatorcontrib><creatorcontrib>Schooler, Nina R</creatorcontrib><creatorcontrib>Marcy, Patricia</creatorcontrib><creatorcontrib>Gibbons, Robert D</creatorcontrib><creatorcontrib>Hendricks Brown, C</creatorcontrib><creatorcontrib>John, Majnu</creatorcontrib><creatorcontrib>Mueser, Kim T</creatorcontrib><creatorcontrib>Penn, David L</creatorcontrib><creatorcontrib>Rosenheck, Robert A</creatorcontrib><creatorcontrib>Addington, Jean</creatorcontrib><creatorcontrib>Brunette, Mary F</creatorcontrib><creatorcontrib>Correll, Christoph U</creatorcontrib><creatorcontrib>Estroff, Sue E</creatorcontrib><creatorcontrib>Mayer-Kalos, Piper S</creatorcontrib><creatorcontrib>Gottlieb, Jennifer D</creatorcontrib><creatorcontrib>Glynn, Shirley M</creatorcontrib><creatorcontrib>Lynde, David W</creatorcontrib><creatorcontrib>Gingerich, Susan</creatorcontrib><creatorcontrib>Pipes, Ronny</creatorcontrib><creatorcontrib>Miller, Alexander L</creatorcontrib><creatorcontrib>Severe, Joanne B</creatorcontrib><creatorcontrib>Kane, John M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Schizophrenia bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Robinson, Delbert G</au><au>Schooler, Nina R</au><au>Marcy, Patricia</au><au>Gibbons, Robert D</au><au>Hendricks Brown, C</au><au>John, Majnu</au><au>Mueser, Kim T</au><au>Penn, David L</au><au>Rosenheck, Robert A</au><au>Addington, Jean</au><au>Brunette, Mary F</au><au>Correll, Christoph U</au><au>Estroff, Sue E</au><au>Mayer-Kalos, Piper S</au><au>Gottlieb, Jennifer D</au><au>Glynn, Shirley M</au><au>Lynde, David W</au><au>Gingerich, Susan</au><au>Pipes, Ronny</au><au>Miller, Alexander L</au><au>Severe, Joanne B</au><au>Kane, John M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial</atitle><jtitle>Schizophrenia bulletin</jtitle><addtitle>Schizophr Bull</addtitle><date>2022-09-01</date><risdate>2022</risdate><volume>48</volume><issue>5</issue><spage>1021</spage><epage>1031</epage><pages>1021-1031</pages><issn>0586-7614</issn><eissn>1745-1701</eissn><abstract>Abstract
To examine long-term effects of early intervention services (EIS) for first-episode psychosis, we compared Heinrichs-Carpenter Quality of Life (QLS) and Positive and Negative Syndrome Scale (PANSS) scores and inpatient hospitalization days over 5 years with data from the site-randomized RAISE-ETP trial that compared the EIS NAVIGATE (17 sites; 223 participants) and community care (CC) (17 sites; 181 participants). Inclusion criteria were: age 15–40 years; DSM-IV diagnoses of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, or psychotic disorder not otherwise specified; first psychotic episode; antipsychotic medication taken for ≤6 months. NAVIGATE-randomized participants could receive NAVIGATE from their study entry date until NAVIGATE ended when the last-enrolled NAVIGATE participant completed 2 years of treatment. Assessments occurred every 6 months. 61% of participants had assessments conducted ≥2 years; 31% at 5 years. Median follow-up length was CC 30 months and NAVIGATE 38 months. Primary analyses assumed data were not-missing-at-random (NMAR); sensitivity analyses assumed data were missing-at-random (MAR). MAR analyses found no significant treatment-by-time interactions for QLS or PANSS. NMAR analyses revealed that NAVIGATE was associated with a 13.14 (95%CI:6.92,19.37) unit QLS and 7.73 (95%CI:2.98,12.47) unit PANSS better improvement and 2.53 (95%CI:0.59,4.47) fewer inpatient days than CC (all comparisons significant). QLS and PANSS effect sizes were 0.856 and 0.70. NAVIGATE opportunity length (mean 33.8 (SD = 5.1) months) was not associated (P = .72) with QLS outcome; duration of untreated psychosis did not moderate (P = .32) differential QLS outcome. While conclusions are limited by the low rate of five-year follow-up, the data support long-term benefit of NAVIGATE compared to community care.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>35689478</pmid><doi>10.1093/schbul/sbac053</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-6606-4507</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0586-7614 |
ispartof | Schizophrenia bulletin, 2022-09, Vol.48 (5), p.1021-1031 |
issn | 0586-7614 1745-1701 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9434430 |
source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | Adolescent Adult Antipsychotic Agents - therapeutic use Diagnostic and Statistical Manual of Mental Disorders Humans Psychotic Disorders - diagnosis Quality of Life Regular Schizophrenia - drug therapy Young Adult |
title | Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T22%3A08%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20During%20and%20After%20Early%20Intervention%20Services%20for%20First-Episode%20Psychosis:%20Results%20Over%205%20Years%20From%20the%20RAISE-ETP%20Site-Randomized%20Trial&rft.jtitle=Schizophrenia%20bulletin&rft.au=Robinson,%20Delbert%20G&rft.date=2022-09-01&rft.volume=48&rft.issue=5&rft.spage=1021&rft.epage=1031&rft.pages=1021-1031&rft.issn=0586-7614&rft.eissn=1745-1701&rft_id=info:doi/10.1093/schbul/sbac053&rft_dat=%3Coup_pubme%3E10.1093/schbul/sbac053%3C/oup_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/35689478&rft_oup_id=10.1093/schbul/sbac053&rfr_iscdi=true |